Petrunia A M, Enenko Iu A
Lik Sprava. 1996 Mar-Apr(3-4):125-7.
The use is studied of the immunomodulating agents splenin and vilosen in a combined therapy of 93 patients with chronic cholestatic disorders of the liver. The above drug combination was found to have a positive effect on both the immune status and condition of microhemodynamics, with the clinical parameters getting improved, duration of remission lengthened.
对93例慢性肝内胆汁淤积症患者联合使用免疫调节剂脾宁和维洛生进行治疗研究。发现上述药物组合对免疫状态和微循环动力学状况均有积极作用,临床指标得到改善,缓解期延长。